Strides Pharma Science has informed that the company’s formulations facility in Alathur, India which was inspected by the USFDA in August 2019 has received the Establishment Inspection Report (EIR), there by confirming the successful closure of the inspections. The inspection conducted in August 2019 had concluded with Zero 483 observations. The facility has recently completed a significant capacity expansion and will support the growth momentum for the US business.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.10 |
| Dr. Reddys Lab | 1238.50 |
| Cipla | 1237.90 |
| Zydus Lifesciences | 942.00 |
| Lupin | 2334.30 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: